Dr. Nicole P. Herbst, MD

Dr. Herbst practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Herbst's NPI, 1962896381, was assigned on March 24, 2015. Dr. Herbst holds Pennsylvania license MD486435.

Dr. Herbst's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Herbst's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Dr. Herbst is also affiliated with WellSpan Good Samaritan Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Herbst to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herbst practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Herbst's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Herbst's licenses on file in 3 states: Pennsylvania, Georgia and Massachusetts.

CMS data shows 145 Medicare services from Dr. Herbst across 5 procedure codes in 2024, for 117 Medicare patients. Medicare paid $14,396 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Dr. Herbst in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Herbst's median patient age at 69, with 54% women.

In 2024, Dr. Herbst wrote 148 Medicare Part D claims for 36 patients. 49% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $968 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Herbst for performance year 2024, reported through an alternative payment model (APM). Dr. Herbst accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Herbst from 1 drug or device company from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $245.